Titre : | Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers (2010) |
Auteurs : | K. H. LEVIN ; M. L. COPERSINO ; S. J. HEISHMAN ; F. LIU ; D. L. KELLY ; D. L. BOGGS ; D. A. GORELICK |
Type de document : | Article : Périodique |
Dans : | Drug and Alcohol Dependence (Vol.111, n°1-2, September 2010) |
Article en page(s) : | 120-127 |
Langues: | Anglais |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés CANNABIS ; SYNDROME DE SEVRAGE ; ADULTE ; RECHUTE ; TOLERANCE ; SEVRAGE |
Résumé : |
Background: Cannabis withdrawal is not recognized in DSM-IV because of doubts about its clinical significance.
Objectives: Assess the phenomenon of cannabis withdrawal and its relationship to relapse in non-treatment-seeking adults. Subjects: Convenience sample of 469 adult cannabis smokers who had made a quit attempt while not in a controlled environment. Methods: Subjects completed a 176-item Marijuana Quit Questionnaire collecting information on sociodemographic characteristics, cannabis use history, and their "most difficult" cannabis quit attempt. Results: 42.4% of subjects had experienced a lifetime withdrawal syndrome, of whom 70.4% reported using cannabis in response to withdrawal. During the index quit attempt, 95.5% of subjects reported >=1 individual withdrawal symptom (mean [SD] 9.5 [6.1], median 9.0); 43.1% reported >=10. Number of withdrawal symptoms was significantly associated with greater frequency and amount of cannabis use, but symptoms occurred even in those using less than weekly. Symptoms were usually of >= moderate intensity and often prompted actions to relieve them. Alcohol (41.5%) and tobacco (48.2%) were used more often than cannabis (33.3%) for this purpose. There was little change during withdrawal in use of other legal or illegal substances. Conclusions: Cannabis withdrawal is a common syndrome among adults not seeking treatment. The intention to relieve withdrawal symptoms can drive relapse during quit attempts, giving cannabis withdrawal clinical significance as a target of treatment. |
Domaine : | Drogues illicites / Illicit drugs |
Affiliation : | Intramural Research Program, National Institute on Drug Abuse, 251 Bayview Blvd., Baltimore, MD 21224, USA |
Cote : | Abonnement |
Accueil